Trial Number
942-19
Condition
Breast Cancer
Participant Age Range
18 years and older
Participant Gender
Any
Enrolling Participants
Yes
Overview
“The Informed Genetics Annotated Patient Registry (The iGAP Registry)”
The interest and arguments in favor of universal genetic testing continue to increase; however, many barriers persist despite a drop in testing costs and increase in information about proper utilization of the information obtained by testing.
The Medneon GAP Registry is a multi-center ongoing database designed to capture information on disease risk assessment, genetic testing, utilization and impact on treatment practices and outcomes to help determine, over time, the most effective use of testing in varied patient populations.